B
BionX Medical Technologies
Developing the PowerFoot One, an ankle-foot device providing active amputees with near-normal gait
About BionX Medical Technologies
BionX Medical Technologies, operating under the brand Ottobock, is a pioneering company in the field of wearable human bionics. The company specializes in developing advanced prosthetic and orthotic solutions that significantly enhance the mobility and quality of life for individuals with physical disabilities. BionX serves a diverse range of clients, including individuals with limb loss, healthcare providers, and rehabilitation centers. The company operates in the global medical device market, focusing on innovation and technology to stay ahead of the competition.
Read full description
BionX's business model revolves around the research, development, and commercialization of high-tech prosthetic devices. Revenue is generated through the sale of these devices, as well as through partnerships with healthcare institutions and insurance companies. The company also invests heavily in R&D to continuously improve its product offerings and maintain its market leadership.
Key clients include hospitals, clinics, and individual patients who require state-of-the-art prosthetic solutions. BionX's market presence is strong in North America, Europe, and Asia, with a growing footprint in emerging markets.
At a glance
- Status
- Acquired
- Founded
- 2007
- Headquarters
- Bedford, United States
- Employees
- 8
- Open positions
- None listed
- Dealroom signal
- 48.5/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Rehabilitation, Disability tech, Pay Per Result, Hard Tech, Prosthetics, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2c
Latest news
Press, funding announcements and product moves mentioning BionX Medical Technologies.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Mar 2017 | $0 | — | Ottobock | ↗ |
| SERIES EOther financing | Dec 2015 | $17M | $68M | Undisclosed | — |
Growth signals
Latest recorded traffic for BionX Medical Technologies is 830 monthly website visits, down 17% over the last three months. BionX Medical Technologies's team declined 20% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
US National Science Foundation
Series A2 investors entered at this stage
General Catalyst- WVWFD Ventures
Series B and later3 investors entered at this stage
Gilde Healthcare
Sigma Partners
Glide Health
Other known investors1 additional known investor
Ottobock
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about BionX Medical Technologies on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See BionX Medical Technologies’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.